Association of CDKAL1 nucleotide variants with the risk of non-syndromic cleft lip with or without cleft palate

J Hum Genet. 2018 Apr;63(4):397-406. doi: 10.1038/s10038-017-0397-4. Epub 2018 Feb 5.

Abstract

Although the aetiology of non-syndromic cleft lip with or without cleft palate (nsCL/P) has been studied extensively, knowledge regarding the role of genetic factors in the pathogenesis of this common craniofacial anomaly is still limited. We conducted a follow-up association study to confirm that CDKAL1 nucleotide variants identified in our genome-wide association study (GWAS) for nsCL/P are associated with the risk of this anomaly. In addition, we performed a sequence analysis of the selected CDKAL1 exons. A mega-analysis of the pooled individual data from the GWAS and a replication study revealed that six out of thirteen CDKAL1 variants were positively replicated and reached the threshold of statistical significance (Ptrend < 3.85E-03). They represented a single association signal and were located within the fifth intron of CDKAL1. The strongest individual variant was rs9356746 with a Ptrend value = 5.71E-06 (odds ratio (OR) = 1.60, 95% confidence interval (CI): 1.30-1.97). Sequencing analysis did not reveal any pathogenic mutations of this gene. This study provides the first evidence that chromosomal region 6p22.3 is a novel susceptibility locus for nsCL/P. The location of the risk variants within the CDKAL1 intronic sequence containing enhancer elements predicted to regulate the SOX4 transcription may suggest that SOX4, rather than CDKAL1, is a potential candidate gene for this craniofacial anomaly.

MeSH terms

  • Alleles
  • Case-Control Studies
  • Cleft Lip / diagnosis*
  • Cleft Lip / genetics*
  • Cleft Palate / diagnosis*
  • Cleft Palate / genetics*
  • DNA Mutational Analysis
  • Female
  • Gene Frequency
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Genome-Wide Association Study
  • Genotype
  • Haplotypes
  • Humans
  • Male
  • Odds Ratio
  • Phenotype
  • Risk
  • Sex Factors
  • tRNA Methyltransferases / genetics*

Substances

  • tRNA Methyltransferases
  • CDKAL1 protein, human